Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
Public ClinicalTrials.gov record NCT00083447. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Multicenter Study of Intratumoral/Interstitial Therapy With TransMID™ Compared to Best Standard of Care in Patients With Progressive and/or Recurrent, Non-Resectable Glioblastoma Multiforme
Study identification
- NCT ID
- NCT00083447
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Xenova Biomedix
- Industry
- Enrollment
- 323 participants
Conditions and interventions
Conditions
Interventions
- TransMID™ Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2004
- Primary completion
- Feb 28, 2006
- Completion
- May 31, 2007
- Last update posted
- Jan 6, 2009
2004 – 2007
United States locations
- U.S. sites
- 24
- U.S. states
- 19
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California-San Diego | La Jolla | California | 92037-0698 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| University of Colorado Health Sciences Center | Denver | Colorado | 80010 | — |
| Yale University | New Haven | Connecticut | 06520 | — |
| Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| University of Iowa Hospitals in Clinics | Cedar Rapids | Iowa | 52242 | — |
| University of Kentucky Medical Center | Lexington | Kentucky | 40536 | — |
| Johns Hopkins Medical Center | Baltimore | Maryland | 21287 | — |
| NINDS National Institutes of Health | Bethesda | Maryland | — | — |
| Fairview University Medical Center | Minneapolis | Minnesota | 55455 | — |
| Saint Louis University Hospital | St Louis | Missouri | 63110 | — |
| Cooper University Hospital | Camden | New Jersey | 08103 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| SUNY Upstate Medical University at Syracuse | Syracuse | New York | 13210 | — |
| New York Medical College | Valhalla | New York | 10595 | — |
| University of North Carolina - Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Legacy Emanuel Hospital and Technology Center | Portland | Oregon | 97227 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | — | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Semmes-Murphey Neurologic Institute | Memphis | Tennessee | 38104 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| Medical College of Virginia | Richmond | Virginia | 23298-0631 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00083447, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2009 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00083447 live on ClinicalTrials.gov.